Solventum Corp
XMUN:KB7
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Solventum Corp
XMUN:KB7
|
US |
|
C
|
China Overseas Land & Investment Ltd
XMUN:CPP
|
HK |
Intrinsic Value
The intrinsic value of Solventum Corp (KB7) under the Base Case is 0.037 EUR per share. Compared with the current market price of 0.028 EUR, the stock appears Undervalued by 24% .
The intrinsic value is calculated using the DCF method.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Solventum Does
Solventum makes products that help hospitals, dentists, and other healthcare providers prevent infection, treat wounds, and manage patient care. Its portfolio includes medical dressings and wound care products, surgical supplies, oral care and dental materials, and software and tools that help providers document and bill patient care. It also sells filtration and purification products used in healthcare and industrial settings.
- Headquarters
- United States of America US
- Employees
- 20 000
- IPO date
- Mar 26, 2024
Solventum has no economic moat
Hospitals, dental practices, and healthcare software buyers can choose among multiple established rivals, and no single protected asset shuts those rivals out across Solventum’s markets. Its products and services compete in separate markets that are not limited to a few providers, so the company’s size alone does not keep new competitors from entering.
Read the full moat analysis
Earnings Waterfall
Solventum Corp
The intrinsic value for Solventum Corp (KB7) under the Base Case is 0.037 EUR.
Compared with the current market price of 0.028 EUR, the stock appears Undervalued by 24% .